Profil
Wen Chu Tseng currently works at ICARES Medicus, Inc., as Vice Chairman from 2021, Icares Medicus Hongkong Ltd., as Director, and AST Products, Inc., as Vice General Manager.
Aktive Positionen von Wen Chu Tseng
Unternehmen | Position | Beginn |
---|---|---|
ICARES MEDICUS, INC. | Chief Tech/Sci/R&D Officer | 18.03.2016 |
Icares Medicus Hongkong Ltd. | Director/Board Member | - |
AST Products, Inc.
AST Products, Inc. Medical SpecialtiesHealth Technology AST Products, Inc. is an ophthalmic surgical products manufacturer based in Billerica, MA. The private company develops and manufactures a range of products used by physicians to treat patients with cataracts, including the Asqelio™ soft hydrophobic intraocular lens, Asqelio™ preloaded IOL delivery systems, and the Pioli™ and Lioli™ IOL delivery systems. The company also provides environmentally-friendly medical coatings for a variety of industries, along with analysis equipment and specially engineered plasma reactors that facilitate the application of their advanced surface treatment technologies. All IOL delivery systems have obtained CE mark and FDA 510(k) clearance. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ICARES MEDICUS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
AST Products, Inc.
AST Products, Inc. Medical SpecialtiesHealth Technology AST Products, Inc. is an ophthalmic surgical products manufacturer based in Billerica, MA. The private company develops and manufactures a range of products used by physicians to treat patients with cataracts, including the Asqelio™ soft hydrophobic intraocular lens, Asqelio™ preloaded IOL delivery systems, and the Pioli™ and Lioli™ IOL delivery systems. The company also provides environmentally-friendly medical coatings for a variety of industries, along with analysis equipment and specially engineered plasma reactors that facilitate the application of their advanced surface treatment technologies. All IOL delivery systems have obtained CE mark and FDA 510(k) clearance. | Health Technology |
Icares Medicus Hongkong Ltd. |